Cargando…
Acute Myeloid Leukemia: An Ever-Changing Disease
Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of thes...
Autores principales: | Nix, Nancy M., Price, Allyson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521118/ http://dx.doi.org/10.6004/jadpro.2019.10.8.12 |
Ejemplares similares
-
Optimizing Use of Newly Approved Agents for Acute Myeloid Leukemia
por: Nix, Nancy M., et al.
Publicado: (2019) -
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges
por: Schlenk, Richard F.
Publicado: (2023) -
Changing the paradigms for the treatment of chronic kidney disease
por: Coyne, Daniel W., et al.
Publicado: (2017) -
Infection-induced epigenetic changes and their impact on the pathogenesis of diseases
por: Fischer, Nicole
Publicado: (2020) -
Infectious disease ecology and evolution in a changing world
por: King, Kayla C., et al.
Publicado: (2023)